Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Semaglutide at a dose of 2.4 mg weekly is the first weekly long-acting GLP-1 RA approved for non-syndromic obesity treatment with a mean weight change of 14.9% in individuals with obesity without diabetes (39) and 9.6% in individuals with obesity and concomitant diabetes (40)
Our offerings include both injectable and oral options such as Wegovy, Zepbound, and the newer oral medications, the Wegovy pill and Foundayo
Focus on Results: We combine the effectiveness of these medications with lifestyle strategies to ensure long-term, sustainable weight loss Michigan
The Myers Cocktail was developed by Dr
US$ 21.51
US$ 20.25
US$ 29.43
US$ 29.04
US$ 22.71
US$ 27.91
US$ 25.48
US$ 26.15
US$ 21.86
